Healthcare provider profile · identity verified

Ashley Monroe, ARNP

Nurse Practitioner · WATERLOO, IA · NPI 1326338724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	257	63
Amlodipine Besylate	Amlodipine Besylate	210	47
Lisinopril	Lisinopril	176	45
Omeprazole	Omeprazole	121	30
Pantoprazole Sodium	Pantoprazole Sodium	107	19
Gabapentin	Gabapentin	106	21
Albuterol Sulfate Hfa	Albuterol Sulfate	103	27
Metoprolol Succinate	Metoprolol Succinate	92	15
Metformin Hcl	Metformin Hcl	91	25
Metformin Hcl Er	Metformin Hcl	91	14
Tamsulosin Hcl	Tamsulosin Hcl	91	15
Hydrochlorothiazide	Hydrochlorothiazide	85	22
Levothyroxine Sodium	Levothyroxine Sodium	72	18
Ozempic	Semaglutide	72	suppressed
Jardiance	Empagliflozin	69	13
Meloxicam	Meloxicam	69	20
Losartan Potassium	Losartan Potassium	68	17
Fluticasone Propionate	Fluticasone Propionate	66	29
Furosemide	Furosemide	64	20
Rosuvastatin Calcium	Rosuvastatin Calcium	60	16
Metoprolol Tartrate	Metoprolol Tartrate	58	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	47	suppressed
Glipizide Er	Glipizide	46	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	44	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Potassium Chloride	Potassium Chloride	40	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Ibuprofen	Ibuprofen	37	suppressed
Mounjaro	Tirzepatide	36	suppressed
Naproxen	Naproxen	36	13
Topiramate	Topiramate	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Allopurinol	Allopurinol	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	11
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Eliquis	Apixaban	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Glipizide	Glipizide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Famotidine	Famotidine	18	suppressed
Baclofen	Baclofen	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Trazodone Hcl	Trazodone Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Atenolol	Atenolol	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Prednisone	Prednisone	11	11
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error